Clinical, Humanistic, and Economic Value of ‘Good ON-Time’ in Advanced Parkinson’s Disease: A Multinational Real-World Study
In this multi-country, real-world study of people with aPD, hourly increases in 'GOT' were associated with improved clinical outcomes, greater humanistic value, and reduced economic burden. Interventions that maximize improvement of 'GOT' should be considered for people with aPD adequately controlled on current therapy.
Authors
- Prasanna L. Kandukuri (ORCID: https://orcid.org/0000-0002-3702-4343)
- Joohi Jimenez‐Shahed (ORCID: https://orcid.org/0000-0002-9772-7569)
- Alexander Gillespie (ORCID: https://orcid.org/0000-0002-9231-3949)
- Connie H. Yan (ORCID: https://orcid.org/0000-0003-1467-4666)
- Angelo Antonini (ORCID: https://orcid.org/0000-0003-1040-2807)
- Irene A. Malaty (ORCID: https://orcid.org/0000-0001-6914-9223)
- Jean‐Philippe Azulay (ORCID: https://orcid.org/0000-0001-6624-3329)
- Jorge Zamudio (ORCID: https://orcid.org/0000-0002-7138-3032)
- Pavnit Kukreja
- Ashwini Parab (ORCID: https://orcid.org/0000-0002-8136-1179)
Institutions
- University of Padua (IT)
- AbbVie (United States) (US)
- University of Florida (US)
- Adelphi Group (United Kingdom) (GB)
- Hôpital de la Timone (FR)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1007/s40120-025-00765-3
- Citations
- 1
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- AbbVie